BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12544510)

  • 1. A functional single-nucleotide polymorphism in the human cytidine deaminase gene contributing to ara-C sensitivity.
    Yue L; Saikawa Y; Ota K; Tanaka M; Nishimura R; Uehara T; Maeba H; Ito T; Sasaki T; Koizumi S
    Pharmacogenetics; 2003 Jan; 13(1):29-38. PubMed ID: 12544510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on the relationship between human cytidine deaminase gene polymorphisms and Ara-C sensitivity].
    Chen XW; Yue LJ; Li CR; Li CG; Shi HS; Zhang M
    Zhonghua Xue Ye Xue Za Zhi; 2008 Jul; 29(7):459-63. PubMed ID: 19035178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant gene products of two natural variants of the human cytidine deaminase gene confer different deamination rates of cytarabine in vitro.
    Kirch HC; Schröder J; Hoppe H; Esche H; Seeber S; Schütte J
    Exp Hematol; 1998 May; 26(5):421-5. PubMed ID: 9590659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Single-nucleotide polymorphisms of the cytidine deaminase gene in childhood with acute leukemia and normal Chinese children].
    Yue LJ; Chen XW; Li CR; Li CG; Shi HS; Zhang M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):699-702. PubMed ID: 18067088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cytidine deaminase: a biochemical characterization of its naturally occurring variants.
    Micozzi D; Carpi FM; Pucciarelli S; Polzonetti V; Polidori P; Vilar S; Williams B; Costanzi S; Vincenzetti S
    Int J Biol Macromol; 2014 Feb; 63():64-74. PubMed ID: 24183806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytidine deaminase genetic variants influence RNA expression and cytarabine cytotoxicity in acute myeloid leukemia.
    Abraham A; Varatharajan S; Abbas S; Zhang W; Shaji RV; Ahmed R; Abraham A; George B; Srivastava A; Chandy M; Mathews V; Balasubramanian P
    Pharmacogenomics; 2012 Feb; 13(3):269-82. PubMed ID: 22304580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Genetic Polymorphisms of Deoxycytidine Kinase and Cytidine Deaminase to Predict Risk of Death in Children with Acute Myeloid Leukemia.
    Medina-Sanson A; Ramírez-Pacheco A; Moreno-Guerrero SS; Dorantes-Acosta EM; Sánchez-Preza M; Reyes-López A
    Biomed Res Int; 2015; 2015():309491. PubMed ID: 26090398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between the expression of the genes encoding the key enzymes for cytarabine metabolism and the pharmacokinetics of cytarabine in the treatment of childhood acute leukemia with high-dose cytarabine].
    Xie XT; Jiang SY; Li BS; Yang LL
    Zhonghua Er Ke Za Zhi; 2008 Apr; 46(4):276-80. PubMed ID: 19099730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to cytosine arabinoside by retrovirally mediated gene transfer of human cytidine deaminase into murine fibroblast and hematopoietic cells.
    Momparler RL; Eliopoulos N; Bovenzi V; Létourneau S; Greenbaum M; Cournoyer D
    Cancer Gene Ther; 1996; 3(5):331-8. PubMed ID: 8894252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of polymorphisms of cytosine arabinoside-metabolizing enzyme gene with therapeutic efficacy for acute myeloid leukemia.
    Xu PP; Chen BA; Feng JF; Cheng L; Xia GH; Li YF; Qian J; Ding JH; Lu ZH; Wang XM; Xu K; Schultz M
    Chin Med J (Engl); 2012 Jun; 125(12):2137-43. PubMed ID: 22884143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive overexpression of the cytidine deaminase gene confers resistance to cytosine arabinoside in vitro.
    Schröder JK; Kirch C; Flasshove M; Kalweit H; Seidelmann M; Hilger R; Seeber S; Schütte J
    Leukemia; 1996 Dec; 10(12):1919-24. PubMed ID: 8946931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased survival in normal karyotype AML with single-nucleotide polymorphisms in genes encoding the AraC metabolizing enzymes cytidine deaminase and 5'-nucleotidase.
    Falk IJ; Fyrberg A; Paul E; Nahi H; Hermanson M; Rosenquist R; Höglund M; Palmqvist L; Stockelberg D; Wei Y; Gréen H; Lotfi K
    Am J Hematol; 2013 Dec; 88(12):1001-6. PubMed ID: 23873772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mice transduced with double-mutant dihydrofolate reductase-cytidine deaminase fusion gene attained protection from high dose chemotherapy].
    Lu P; Lu Y; Pang K; Wang SB; Chen JQ; Xu HM; Wang JK; Zhao SC
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):998-1001. PubMed ID: 16194358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfection of murine fibroblast cells with human cytidine deaminase cDNA confers resistance to cytosine arabinoside.
    Momparler RL; Laliberté J; Eliopoulos N; Beauséjour C; Cournoyer D
    Anticancer Drugs; 1996 May; 7(3):266-74. PubMed ID: 8791999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability in transport and biotransformation of cytarabine is associated with its toxicity in peripheral blood mononuclear cells.
    Parmar S; Seeringer A; Denich D; Gärtner F; Pitterle K; Syrovets T; Ohmle B; Stingl JC
    Pharmacogenomics; 2011 Apr; 12(4):503-14. PubMed ID: 21521023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexpression of cytidine deaminase and mutant dihydrofolate reductase by a bicistronic retroviral vector confers resistance to cytosine arabinoside and methotrexate.
    Beauséjour CM; Le NL; Létourneau S; Cournoyer D; Momparler RL
    Hum Gene Ther; 1998 Nov; 9(17):2537-44. PubMed ID: 9853520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Creation of zebularine-resistant human cytidine deaminase mutants to enhance the chemoprotection of hematopoietic stem cells.
    Ruan H; Qiu S; Beard BC; Black ME
    Protein Eng Des Sel; 2016 Dec; 29(12):573-582. PubMed ID: 27160178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular localization of human cytidine deaminase. Identification of a functional nuclear localization signal.
    Somasekaram A; Jarmuz A; How A; Scott J; Navaratnam N
    J Biol Chem; 1999 Oct; 274(40):28405-12. PubMed ID: 10497201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GATA1, cytidine deaminase, and the high cure rate of Down syndrome children with acute megakaryocytic leukemia.
    Ge Y; Stout ML; Tatman DA; Jensen TL; Buck S; Thomas RL; Ravindranath Y; Matherly LH; Taub JW
    J Natl Cancer Inst; 2005 Feb; 97(3):226-31. PubMed ID: 15687366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of drug-resistant transduced cells with cytosine nucleoside analogs using the human cytidine deaminase gene.
    Beauséjour CM; Eliopoulos N; Momparler L; Le NL; Momparler RL
    Cancer Gene Ther; 2001 Sep; 8(9):669-76. PubMed ID: 11593336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.